Continuous therapy in HHV-8 negative Multicentric Castleman Disease and prolonged progression-free survival.

MLA

Liu, Yi, et al. “Continuous Therapy in HHV-8 Negative Multicentric Castleman Disease and Prolonged Progression-Free Survival.” Journal of Hematology & Oncology, vol. 17, no. 1, Aug. 2024, pp. 1–5. EBSCOhost, https://doi.org/10.1186/s13045-024-01588-9.

APA

Liu, Y., Yin, X., Ding, S., Ge, J., Ma, L., Yang, M., Luo, X., Zhong, C., Fang, S., Yao, Q., Zhu, L., Yu, W., Mao, L., Wei, J., Ye, X., Zhou, D., Tong, H., Meng, H., Jin, J., & You, L. (2024). Continuous therapy in HHV-8 negative Multicentric Castleman Disease and prolonged progression-free survival. Journal of Hematology & Oncology, 17(1), 1–5. https://doi.org/10.1186/s13045-024-01588-9

Chicago

Liu, Yi, Xuejiao Yin, Shengnan Ding, Jiaying Ge, Liya Ma, Min Yang, Xuxia Luo, et al. 2024. “Continuous Therapy in HHV-8 Negative Multicentric Castleman Disease and Prolonged Progression-Free Survival.” Journal of Hematology & Oncology 17 (1): 1–5. doi:10.1186/s13045-024-01588-9.